Su Chu

2.7k total citations
29 papers, 1.8k citations indexed

About

Su Chu is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Su Chu has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 15 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Su Chu's work include Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Eosinophilic Disorders and Syndromes (7 papers). Su Chu is often cited by papers focused on Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Eosinophilic Disorders and Syndromes (7 papers). Su Chu collaborates with scholars based in United States, United Kingdom and Norway. Su Chu's co-authors include Ravi Bhatia, David S. Snyder, Tessa L. Holyoake, Allen Lin, Melissa Holtz, Stephen J. Forman, Tinisha McDonald, Janardan K. Reddy, Mamta Gupta and Soheil S. Dadras and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Su Chu

29 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Chu United States 19 1.1k 749 703 380 234 29 1.8k
Franck Gesbert France 20 585 0.5× 1.1k 1.5× 374 0.5× 170 0.4× 498 2.1× 35 2.0k
Valerie L. Goss United States 11 338 0.3× 1.7k 2.2× 264 0.4× 146 0.4× 260 1.1× 15 2.2k
Persio Dello Sbarba Italy 29 663 0.6× 1.1k 1.5× 418 0.6× 85 0.2× 442 1.9× 78 2.3k
Marion Jeanne United States 16 485 0.4× 1.4k 1.9× 145 0.2× 73 0.2× 335 1.4× 23 2.1k
Karen Keeshan United Kingdom 26 700 0.6× 1.4k 1.8× 207 0.3× 50 0.1× 302 1.3× 55 2.2k
Philip D. Cotter United States 26 146 0.1× 1.3k 1.8× 247 0.4× 274 0.7× 200 0.9× 95 2.4k
Vincent Mignotte France 16 636 0.6× 1.4k 1.8× 401 0.6× 111 0.3× 69 0.3× 20 2.1k
Sachiko I. Blaber United States 31 862 0.8× 826 1.1× 1.2k 1.7× 63 0.2× 488 2.1× 45 2.1k
Alison M. Michie United Kingdom 27 463 0.4× 1.2k 1.6× 347 0.5× 51 0.1× 486 2.1× 67 2.5k
Elisabetta Rovida Italy 28 392 0.4× 1.1k 1.4× 209 0.3× 61 0.2× 395 1.7× 78 2.0k

Countries citing papers authored by Su Chu

Since Specialization
Citations

This map shows the geographic impact of Su Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Chu more than expected).

Fields of papers citing papers by Su Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Chu. The network helps show where Su Chu may publish in the future.

Co-authorship network of co-authors of Su Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Su Chu. A scholar is included among the top collaborators of Su Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Chu. Su Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Bijender, Su Chu, Steven T. Rosen, et al.. (2017). Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia. Leukemia Research. 59. 124–135. 24 indexed citations
2.
Vishwakarma, Bandana Ajay, et al.. (2017). Hoxa9 and Hoxa10 induce CML myeloid blast crisis development through activation of Myb expression. Oncotarget. 8(58). 98853–98864. 3 indexed citations
3.
Zhang, Bin, Su Chu, Puneet Agarwal, et al.. (2016). Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor–treated CML stem cells. Blood. 128(23). 2671–2682. 89 indexed citations
4.
Wang, Zhiqiang, Zheng Liu, Xiwei Wu, et al.. (2014). ATRA-Induced Cellular Differentiation and CD38 Expression Inhibits Acquisition of BCR-ABL Mutations for CML Acquired Resistance. PLoS Genetics. 10(6). e1004414–e1004414. 27 indexed citations
5.
Wang, Lisheng, Ling Li, Liang Li, et al.. (2014). MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors. Blood. 125(8). 1302–1313. 128 indexed citations
6.
7.
Sorrell, April, Carin R. Espenschied, Wei Wang, et al.. (2012). Hereditary Leukemia Due to Rare <i>RUNX</i>1c Splice Variant (L472X) Presents with Eczematous Phenotype. International Journal of Clinical Medicine. 3(7). 607–613. 12 indexed citations
8.
Zhang, Bin, Adam C. Strauss, Su Chu, et al.. (2010). Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate. Cancer Cell. 17(5). 427–442. 199 indexed citations
9.
Pellicano, Francesca, Bin Zhang, Lisa Crawford, et al.. (2010). Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. Blood. 115(11). 2241–2250. 44 indexed citations
10.
König, Helmut, Mhairi Copland, Su Chu, et al.. (2008). Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells. Cancer Research. 68(23). 9624–9633. 83 indexed citations
11.
Chu, Su, Allen Lin, Tinisha McDonald, et al.. (2008). Persistence of Leukemia Stem Cells in Chronic Myelogenous Leukemia Patients in Complete Cytogenetic Remission on Imatinib Treatment for 5 Years. Blood. 112(11). 194–194. 8 indexed citations
12.
Chu, Su. (2007). Failure analysis and reliability evaluation of mono-bucket excavator's hydraulic system. 1 indexed citations
13.
Strauss, Adam C., Su Chu, Tessa L. Holyoake, & Ravi Bhatia. (2007). Effective Induction of Apoptosis in Chronic Myeloid Leukemia CD34+ Cells by the Histone Deacetylase Inhibitor LAQ824 in Combination with Imatinib.. Blood. 110(11). 1031–1031. 9 indexed citations
14.
Modi, Hardik, Tinisha McDonald, Su Chu, et al.. (2007). Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells. Blood. 109(12). 5411–5421. 49 indexed citations
15.
Sahu, Ravi P., Ajay Aggarwal, Ajay M. Shah, et al.. (2007). Etiology of Early-Onset Type 2 Diabetes in Indians: Islet Autoimmunity and Mutations in Hepatocyte Nuclear Factor 1α and Mitochondrial Gene. The Journal of Clinical Endocrinology & Metabolism. 92(7). 2462–2467. 17 indexed citations
16.
Bhatia, Ravi, David S. Snyder, Tinisha McDonald, et al.. (2004). Feasibility and Efficacy of Mobilization of BCR/ABL- PBSC in CML Patients Receiving Imatinib.. Blood. 104(11). 2858–2858. 2 indexed citations
17.
Chu, Su, Melissa Holtz, Mamta Gupta, & Ravi Bhatia. (2003). BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells. Blood. 103(8). 3167–3174. 142 indexed citations
18.
Kim, Seong‐Hun, John W.M. Creemers, Su Chu, Gopal Thinakaran, & Sangram S. Sisodia. (2002). Proteolytic Processing of Familial British Dementia-associated BRI Variants. Journal of Biological Chemistry. 277(3). 1872–1877. 46 indexed citations
19.
Kim, Seong‐Hun, Bridget E. Berechid, Sarah Bingham, et al.. (2000). Requirement for Presenilin 1 in Facilitating Jagged 2-Mediated Endoproteolysis and Signaling of Notch 1. Journal of Molecular Neuroscience. 15(3). 189–204. 43 indexed citations
20.
Chu, Ruiyin, Usha Varanasi, Su Chu, et al.. (1995). Overexpression and Characterization of the Human Peroxisomal Acyl-CoA Oxidase in Insect Cells. Journal of Biological Chemistry. 270(9). 4908–4915. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franck Gesbert Breakdown of academic impact, for papers by Valerie L. Goss Breakdown of academic impact, for papers by Persio Dello Sbarba Breakdown of academic impact, for papers by Marion Jeanne Breakdown of academic impact, for papers by Karen Keeshan Breakdown of academic impact, for papers by Philip D. Cotter Breakdown of academic impact, for papers by Vincent Mignotte Breakdown of academic impact, for papers by Sachiko I. Blaber Breakdown of academic impact, for papers by Alison M. Michie Breakdown of academic impact, for papers by Elisabetta Rovida
Rankless by CCL
2026